142 related articles for article (PubMed ID: 348294)
1. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
Maurice P; Glidewell O; Jacquillat C; Silver RT; Carey R; Pas AT; Cornell CJ; Burningham RA; Nissen NI; Holland JF
Cancer; 1978 May; 41(5):1658-63. PubMed ID: 348294
[TBL] [Abstract][Full Text] [Related]
2. The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study.
Hansen HH; Selawry OS; Pajak TF; Spurr CL; Falkson G; Brunner K; Cuttner J; Nissen NI; Holland JF
Cancer; 1981 Jan; 47(1):14-8. PubMed ID: 7006789
[TBL] [Abstract][Full Text] [Related]
3. Results with CCNU in resistant Hodgkin's and non-Hodgkin's lymphoma.
Stolinsky DC; Solomon J; Weiner JM; Bateman JR
Oncology; 1976; 33(5-6):271-3. PubMed ID: 800240
[TBL] [Abstract][Full Text] [Related]
4. Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
Durant JR; Bartolucci A; Gams RA; Dorfman RF; Velez-Garcia E
Cancer Treat Rep; 1976 Jun; 60(6):781-7. PubMed ID: 782700
[TBL] [Abstract][Full Text] [Related]
5. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
Posey LE; Morgan LR
Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
[TBL] [Abstract][Full Text] [Related]
6. Results with methyl-CCNU and DTIC in metastatic melanoma.
Costanza ME; Nathanson L; Schoenfeld D; Wolter J; Colsky J; Regelson W; Cunningham T; Sedransk N
Cancer; 1977 Sep; 40(3):1010-5. PubMed ID: 332319
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for mustard-resistant ovarian adenocarcinoma: a randomized trial for CCNU and methyl-CCNU.
Omura G; DiSaia P; Blessing J; Boronow R; Hreshchyshyn M; Park R
Cancer Treat Rep; 1977 Nov; 61(8):1533-5. PubMed ID: 922756
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
Kurnick JE; White M; Ware DE; Robinson WA
Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of intravenously- administered methyl CCNU in the treatment of advanced sarcomas.
Chang P; Levine MA; Wiernik PH; Walker MD
Cancer; 1976 Feb; 37(2):615-9. PubMed ID: 766946
[TBL] [Abstract][Full Text] [Related]
10. Methyl CCNU and adriamycin for patients with metastatic sarcomas: a Southwest Oncology Group study.
Rivkin SE; Gottlieb JA; Thigpen T; El Mawla NG; Saiki J; Dixon DO
Cancer; 1980 Aug; 46(3):446-51. PubMed ID: 7397620
[TBL] [Abstract][Full Text] [Related]
11. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
Stolinsky DC; Bull FE; Pajak TF; Bateman JR
Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
Diggs CH; Wiernik PH; Levi JA; Kvols LK
Cancer; 1977 May; 39(5):1949-54. PubMed ID: 870162
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.
Omura GA; Shingleton HM; Creasman WT; Blessing JA; Boronow RC
Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400
[No Abstract] [Full Text] [Related]
14. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
[No Abstract] [Full Text] [Related]
15. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
Douglass HO; Lavin PT; Moertel CG
Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
[TBL] [Abstract][Full Text] [Related]
16. Sequential and combination chemotherapy of advanced gastric cancer.
Moertel CG; Mittelman JA; Bakemeier RF; Engstrom P; Hanley J
Cancer; 1976 Aug; 38(2):678-82. PubMed ID: 788891
[TBL] [Abstract][Full Text] [Related]
17. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
Cedermark BJ; Didolkar MS; Elias EG
Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
[TBL] [Abstract][Full Text] [Related]
18. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
Zeller WJ; Berger M
Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced malignancy with CCNU (NSC 79037): a phase II cooperative study with long-term follow up.
Cruz AB; Metter G; Armstrong DM; Aust JB; Fletcher WS; Wilson WL; Richardson JD
Cancer; 1976 Sep; 38(3):1069-76. PubMed ID: 953955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
